Kogure Y, Hashimoto H, Oki M. A Randomized Phase III Study of Pembrolizumab Versus Pembrolizumab-Carboplatin-Pemetrexed for Locally Advanced or Metastatic Nonsquamous Non-small-cell Lung Cancer with PD-L1 50% or more (LAPLACE-50): Study Protocol. Clin Lung Cancer 2021 Feb 19. pii: S1525-7304(21)00031.
PMID: 34053861